Author:
Díaz-Marsá Marina,Ayad-Ahmed Wala,López-Villatoro José Manuel,Fernández-Rodrigues Verónica,Ruiz-Guerrero Francisco,Gómez del Barrio Andrés,Beato- Fernández Luis,Polo-Montes Filomena,León-Velasco Magdalena,Torre- Luque Alejandro de la,Carrasco José Luis,Caso Javier R.,MacDowell Karina S.,Leza Juan C.
Funder
Instituto de Salud Carlos III
European Regional Development Fund
Reference45 articles.
1. Tumour necrosis factor alpha and oxidative stress as maintaining factors in the evolution of anorexia nervosa;Agnello;Eat. Weight Disord. -Stud. Anorex., Bulim. Obes.,2012
2. Levels of tumour necrosis factor-alpha and interleukin-6 in severely Ill patients with eating disorders;Ahrén-Moonga;Neuropsychobiology,2011
3. DSM-5 Task Force;American Psychiatric Association,2013
4. Armocida, B., Monasta, L., Sawyer, S., Bustreo, F., Segafredo, G., Castelpietra, G., Ronfani, L., Pasovic, M., Hay, S., GBD 2019 Europe NCDs in Adolescents Collaborators, Perel, P., Beran, D., 2022. Burden of non-communicable diseases among adolescents aged 10- 24 years in the EU, 1990–2019: a systematic analysis of the Global Burden of Diseases Study 2019. The Lancet. Child & adolescent health, 6(6), 367–383. https://doi.org/10.1016/S2352–4642(22)00073–6.
5. Plasma concentrations of interleukin-1-beta, interleukin-6 and tumor necrosis factor-alpha, and of their soluble receptors and receptor antagonist in anorexia nervosa;Brambilla;Psychiatry Res.,2001